Institutional Ownership Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL). We have compiled data on the 107 institutions that hold shares in the stock, with a total of 58 Million shares, which have been reported (via 13F filing form) to have a value of $77.2 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
548,629
shares
|
$729,676
0.05% of portfolio
|
Q3 2025
Added 107.16%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
532,678
shares
|
$708,461
0.0% of portfolio
|
Q3 2025
Added 311.44%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
530,582
shares
|
$705,674
0.0% of portfolio
|
Q4 2024
Reduced 49.72%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
490,000
shares
|
$651,700
0.5% of portfolio
|
Q2 2023
New holding
|
|
|
Almitas Capital LLC
Santa Monica, CA |
Nov 14, 2025 Q3 2025 |
457,322
shares
|
$608,238
0.33% of portfolio
|
Q3 2025
Reduced 71.4%
|
|
|
Stonepine Capital Management, LLC
Bend, OR |
Nov 13, 2025 Q3 2025 |
453,800
shares
|
$603,554
0.56% of portfolio
|
Q3 2025
Added 316.29%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
380,822
shares
|
$506,493
0.0% of portfolio
|
Q3 2025
Added 20.96%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
345,155
shares
|
$459,056
0.0% of portfolio
|
Q3 2025
Reduced 59.95%
|
|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2025 Q3 2025 |
316,550
shares
|
$421,011
0.08% of portfolio
|
Q3 2025
Reduced 83.55%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
271,790
shares
|
$361,480
0.0% of portfolio
|
Q2 2025
Reduced 79.41%
|
|
|
Creative Planning
Overland Park, KS |
Nov 14, 2025 Q3 2025 |
260,000
shares
|
$345,800
0.0% of portfolio
|
Q3 2025
Added 756.95%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
201,109
shares
|
$267,474
0.0% of portfolio
|
Q3 2025
Added 37.96%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
185,032
shares
|
$246,092
0.0% of portfolio
|
Q3 2025
Reduced 44.93%
|
|
|
Mayo Clinic
Rochester, MN |
Nov 12, 2024 Q3 2024 |
175,000
shares
|
$232,750
23.63% of portfolio
|
Q3 2024
Reduced 6.49%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
173,621
shares
|
$230,915
0.0% of portfolio
|
Q3 2025
Added 11.5%
|
|
|
Sei Investments CO
Oaks, PA |
Nov 13, 2025 Q3 2025 |
167,100
shares
|
$222,243
0.0% of portfolio
|
Q2 2025
Reduced 17.45%
|
|
|
Wealth Enhancement Advisory Services, LLC
|
Oct 29, 2025 Q3 2025 |
166,290
shares
|
$221,165
0.0% of portfolio
|
Q3 2025
Reduced 4.43%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
161,470
shares
|
$214,755
0.0% of portfolio
|
Q3 2025
Added 0.0%
|
|
|
Graham Capital Management, L.P.
Rowayton, CT |
Nov 14, 2025 Q3 2025 |
152,147
shares
|
$202,355
0.0% of portfolio
|
Q3 2025
Added 328.89%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2025 Q3 2025 |
120,448
shares
|
$160,195
0.0% of portfolio
|
Q3 2025
Reduced 7.25%
|
|
|
Quarry LP
New York, NY |
Nov 14, 2025 Q3 2025 |
108,750
shares
|
$144,637
0.04% of portfolio
|
Q3 2025
Added 3.57%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
106,965
shares
|
$142,263
0.0% of portfolio
|
Q3 2025
Reduced 75.41%
|
|
|
Panagora Asset Management Inc
Boston, MA |
Nov 13, 2025 Q3 2025 |
97,898
shares
|
$130,204
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
94,119
shares
|
$125,178
0.0% of portfolio
|
Q3 2025
Reduced 23.76%
|
|
|
Rbf Capital, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
80,000
shares
|
$106,400
0.01% of portfolio
|
Q2 2025
New holding
|
|